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Previewsenhanced activity but destabilized the
enzyme, and was not incorporated into
the final mutant OB-1. There are 15 muta-
tions in OB-1, including five (two synony-
mous) in the a-factor leader sequence,
that collectively contribute to both the
expression/secretion level and specific
activity while retaining wild-type thermo-
stability. As such, mutant OB-1 is more
thermally stable than some native thermo-
stable fungal laccases and also highly
resistant to organic solvents and acidity,
making it an excellent candidate for
industrial applications. In addition, the
general nature of the mutant leader
peptide is likely to enhance secretion
levels when used with other proteins.
Laboratory evolution of highly active
enzymes tends to cause the engineered
enzymes to lose activity toward sub-
strates not used during screening, a
consequence that may result from the
altered shapes of enzyme active sites.
To maintain the broad substrate speci-
ficity of PM1 laccase, Mate´ et al. (2010)
employed two representative substrates
in their screen. While such a strategy is
not always effective in maintaining broad
substrate specificity, the resulting mutant
OB-1 exhibits increased specific activity920 Chemistry & Biology 17, September 24, 2toward all three substrates examined
with only a slight preference for ABTS
rather than guaiacol when compared
with the third-generation mutant. In some
applications, such as delignification, a
chemical mediator is usually used to indi-
rectly oxidize phenol and nonphenol
compounds (Call and Mucke, 1997). As
such, a highly active laccase toward a
chemical mediator (for example, 1-hy-
droxybenzotriazole for delignification)
would eliminate the necessity of maintain-
ing broad substrate specificity in laccase-
directed evolution. In addition, the
inadvertent introduction of destabilizing
mutation F454S could also have been
circumvented if a thermal stability screen
were incorporated into the initial library
screening, though such a screen may
not have been feasible in the presence
of poor total enzymatic activity. Neverthe-
less, this fine piece of work represents
another interesting example of how
directed evolution and rational enzyme
design can be combined for the engi-
neering of protein function, and how
such a strategy could enhance the effi-
ciency of searching protein sequence
space (Arnold, 2006; Turner, 2009). More
immediately, Mate´ et al. (2010) have010 ª2010 Elsevier Ltd All rights reserveddeveloped a heterologous expression
system for efficiently producing HRPLs,
which has been a major hurdle for indus-
trial applications of laccases, and the
highly active and stable OB-1 is an excel-
lent starting point for various biotechno-
logical applications of HRPLs.REFERENCES
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Riboswitches are mRNA-based elements that regulate gene expression via binding of a specific ligand.
Breaker and coworkers have now discovered a novel type of regulatory RNA motif that acts by c-di-GMP-
dependent control of a self-splicing group I intron ribozyme (Lee et al., 2010).Riboswitches are widespread regulatory
motifs found in mRNAs. They are usually
composed of an aptamer domain facili-
tating ligand binding and a second
domain termed an expression platform
(Roth and Breaker, 2009). The latter reor-
ganizes in response to ligand binding to
the aptamer domain, resulting in altered
gene expression. Commonly one out oftwo different mechanisms is employed:
either the formation of a Rho-independent
termination structure is regulated, result-
ing in the premature termination of tran-
scription, or the formation of a stem-loop
structure that masks the ribosome bind-
ing site is controlled, resulting in the regu-
lation of translation initiation. Exceptions
are represented by riboswitches oper-ating in eukarya, as well as an autocata-
lytic motif (the glmS riboswitch in certain
eubacteria) that cleaves the mRNA in
response to glucosamine-6-phosphate
binding (Winkler et al., 2004).
Now Breaker and coworkers have
described a novel type of riboswitch that
contains a self-splicing ribozyme as an
expression platform (Lee et al., 2010).
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PreviewsThe riboswitch was discovered during
the investigation of a new aptamer motif
identified by bioinformatics approaches
(Weinberg et al., 2010). The novel motif
binds the bacterial second messenger
30-50-cyclic-di-guanylic acid (c-di-GMP),
responsible for signaling microbial pro-
cesses such as biofilm formation, viru-
lence, and motility. This aptamer differs
from the first class of c-di-GMP aptamers
present in recently discovered ribos-
witches (Sudarsan et al., 2008). The novel
motif (termed c-di-GMP-II) is frequently
found inClostridia and some other eubac-
teria. Predominantly, these c-di-GMP-II
motifs are connected to an expression
platform controlling the termination of
transcription. One motif, however, was
unusually distant (about 600 nt upstream)
from the open reading frame (ORF).
When they looked closer, Breaker and
coworkers discovered that this stretch
of RNA residing between the c-di-
GMP-II aptamer and the ORF had all of
the characteristics of a group I intron
ribozyme.
Group I introns catalyze a self-splicing
reaction by binding guanosine or a corre-
sponding nucleotide that then attacks
a 50-splice site (50-SS). Next, the resulting
50-exon attacks at the 30-SS, generating
the exon-exon splice product and the
free intron containing the ribozyme.Within
group I introns, protein-coding ORFs
are often found. For example, transpo-
sases are frequently associated with self-
splicing ribozymes. The combination of
both activities generates a mobile selfish
genetic element that is able to insert into
RNAs without doing much harm to the
host genome (Haugen et al., 2005). In
Clostridium difficile, nine out of ten group
I introns are found in such a context. On
the other hand, the intron that carries
a c-di-GMP-II aptamer upstream is not
associated with a transposase gene,
pointing at the possibility that a locally
defined function might be attributable to
the ribozyme at this position.By a series of sophisticated experi-
ments, Breaker and coworkers examined
the reactivity of the c-di-GMP aptamer/
group I intron combination. It seems that
the intact, full-length mRNA is not trans-
lated because the start codon is seques-
tered by interactions with a part of the
intron sequence. The second messenger
binding to the c-di-GMP-II aptamer con-
trols where the ribozyme-mediated initial
attack of a guanosine triphosphate (GTP)
occurs. In absence of c-di-GMP, the
mRNA is cleaved just 4 nt upstream of
the start codon, resulting in an mRNA
that is not translated due to the absence
of a ribosome-binding site. An alternate
site is attacked and splicing occurs only
in the presence of c-di-GMP, assembling
an efficient ribosome binding site as
well as cutting out the intron ribozyme
together with the sequence that masked
the start codon. Hence, it is proposed
that a functional message that can be
translated is generated by the ligand-
controlled ribozyme clipping itself from
the mRNA.
The discovery by the Breaker group
reveals how nature combines distinct
RNA functions such as ligand binding
and catalytic activity in a highly modular
fashion. An artificial system that exploits
the same modularity logic and is com-
posed of a theophylline-regulated group
I intron was described previously by
Ellington and coworkers (Thompson et al.,
2002). It is fascinating to observe that life
actually makes use of mechanisms that
researchers have designed and con-
structed in order to prove the versatility
of RNA for such purposes. However, one
could wonder why such a ‘‘noneconomic’’
way of control is implemented, since
the group I intron is a rather large ele-
ment compared with the frequently
used expression platforms in ribos-
witches described above. As evidenced
by several examples of c-di-GMP-depen-
dent riboswitches with at least two dif-
ferent classes of aptamers, there areChemistry & Biology 17, September 24, 2010more nucleotide-efficient ways of control-
ling gene expression by this second
messenger.
On the other hand, the discovered allo-
steric group I ribozyme possesses a
further property that is absent in other
c-di-GMP-sensing elements: since the
group I intron requires GTP as cofactor
for the self-splicing reaction, the ribos-
witch may be regarded as a tandem
switch, sensing both GTP and c-di-GMP
simultaneously. In the presence of GTP
and c-di-GMP, an RNA product that gets
translated is produced, resembling a
Boolean logic AND gate. Such tandem
riboswitches have been discovered
before where two distinct RNA regulators
act in concert in one 50-untranslated
region (Sudarsan et al., 2006). Further
studies, also with respect to the function
of the gene product under control of
the novel c-di-GMP-II riboswitch that is
currently annotated as a putative surface
protein, will be necessary in order to
clarify whether a potential tandem prop-
erty of the switch is indeed useful in this
context.REFERENCES
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